Trainings and Resources

64,000 people died from an overdose in the U.S. in 2016. Fentanyl-related deaths are up 540% in the last 3 years. In 2016 72% of the 1,374 fatal overdoses in NYC involved heroin and/or fentanyl

The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine is to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction. This document draws on existing empirical evidence and clinical judgment on drug testing with the goal of improving the quality of care that people with addiction receive

This letter to the editor in The New England Journal of Medicine evaluates the use of an undisclosed, unsanctioned safe consumption site in the United States. The letter begins by discussing the positive outcomes seen through sanctioned safe consumption injection sites in other countries.

The Foundation for Opioid Response (FORE) efforts hosted a webinar on April 23, 2020: Caring for Pregnant and Parenting Women with OUD During the Coronavirus (COVID-19) Pandemic.